Bunion Market to Experience Robust Growth by 2034 - DelveInsight Analysis | Highlighting Key Players Like Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wright Medical

Bunion emerging therapies, such as Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are expected to significantly drive market growth by offering innovative, minimally invasive alternatives with improved patient outcomes and faster recovery times. These advancements, combined with rising awareness, increasing prevalence-especially among women-and growing demand for effective surgical and non-surgical interventions, are set to propel the bunion market forward in the coming years.

DelveInsight has launched a new report on "Bunion - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the bunion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Request for a detailed bunion market sample report @ https://www.delveinsight.com/report-store/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Some of the key facts of the Bunion Market Report:
According to DelveInsight, in 2023, there were approximately 190 million prevalent cases of Hallux Valgus in the 7MM. Among these regions, the United States holds the largest market share for bunion treatment.
In 2023, the US recorded approximately 100 million cases of mild hallux valgus, around 40 million moderate cases, and roughly 10 million severe cases. The condition is significantly more prevalent among females, who are 2 to 3 times more likely to be affected than males.
Currently, the pipeline for bunion treatments is limited, with most emerging therapies, such as PRF-110 and CPL-01, targeting symptom relief rather than addressing the root cause of the condition.
DePuy Synthes (Johnson & Johnson) received FDA 510(k) clearance for its TriLEAPTM Lower Extremity Anatomic Plating System. This modular system is designed for various foot and ankle procedures, including bunionectomies, and is expected to be available in the US in 2024.
In August 2024, PainReform reported a significant development by successfully determining the optimal delivery method for PRF-110 in bunionectomy procedures, positioning it as a leading option for managing post-surgical pain.
Key Bunion companies, such as Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wright Medical, and others, are evaluating new drugs to improve the Bunion treatment landscape.
Promising Bunion pipeline therapies in various stages of development include CPL-01, PRF-110, and others.
Key benefits of the Bunion market report:
The bunion market report covers a descriptive overview and comprehensive insights into the Bunion Epidemiology and market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan).
The Bunion market report provides insights into the current and emerging therapies.
The Bunion market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Bunion market report offers an edge that helps in developing business strategies by understanding the trends shaping and driving the Bunion market.

Got queries? Click here to know more about the bunion market landscape https://www.delveinsight.com/sample-request/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Bunion Overview

Hallux valgus, or bunion, is a common foot deformity where the big toe deviates laterally at the first metatarsophalangeal joint, forming a noticeable bony bump on the inner foot. It develops due to a mix of genetic predisposition, anatomical factors, and environmental influences-such as wearing tight or high-heeled shoes-which can worsen the condition. The shifting of the first metatarsal bone and rotation of the big toe often causes pain, especially during walking or weight-bearing.

Diagnosis is primarily clinical, involving a physical examination and a medical history. Symptoms typically include pain, swelling, and redness over the bunion, often aggravated by tight footwear. Doctors assess toe alignment and any complications like calluses or bursitis. X-rays are used to confirm the diagnosis and measure the severity of deformity through the hallux valgus angle (HVA) and the intermetatarsal angle (IMA). An HVA over 15° indicates the presence of hallux valgus, with severity categorized as mild, moderate, or severe.

Bunion Market Outlook

Top companies in the bunion treatment space- including Concentric Analgesics, Pacira Pharmaceuticals, Cali Pharmaceuticals, and PainReform-are actively advancing their key drug candidates through various phases of clinical development. Their goal is to explore the potential of these therapies for treating bunions.

In 2023, conservative treatment accounted for approximately 40% of the revenue share in the 7MM bunion market, while bunionectomy remained the leading approach, capturing about 60% of the market. Within the EU4 and the UK, Germany led in revenue generation with around USD 700 million, and France contributed roughly 20% of the total bunion market share in that region.

Explore how the bunion market is rising in the upcoming years @ https://www.delveinsight.com/report-store/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Bunion Marketed Drugs
Magnezix CS: Syntellix
Lapiplasty 3-Dimensional Bunion Correction: Treace Medical Concepts
PROstep Minimally Invasive Surgery System: Stryker

Bunion Emerging Drugs

CPL-01: Cali Pharmaceuticals
PRF-110: PainReform

To know more about the therapies that are driving the Bunion treatment market, visit: https://www.delveinsight.com/sample-request/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Bunion Market Report

Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Bunion Companies: Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wright medical, and others
Key Bunion Therapies: CPL-01, PRF-110, and others.
Bunion Therapeutic Assessment: Bunion current marketed and bunion emerging therapies
Bunion Market Dynamics: Bunion market drivers and bunion market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Bunion Unmet Needs, KOL's views, Analyst's views, Bunion Market Access and Reimbursement

Table of Contents

1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Bunion Patient Share (%) Overview at a Glance
5. Bunion Market Overview at a Glance
6. Bunion Disease Background and Overview
7. Bunion Epidemiology and Patient Population
8. Country-Specific Patient Population of Bunion
9. Bunion Current Treatment and Medical Practices
10. Unmet Needs
11. Bunion Emerging Therapies
12. Bunion Market Outlook
13. Country-Wise Bunion Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Bunion Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Click here to read more about bunion Market Outlook 2034 @ https://www.delveinsight.com/report-store/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Related Reports:

Bunion Pipeline Insights, DelveInsight

"Bunion Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Bunion market. A detailed picture of the Bunion pipeline landscape is provided, including a disease overview and treatment guidelines for Bunion.

Contact Info:

Kritika Rehani, Team Leader Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.